-
Je něco špatně v tomto záznamu ?
Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine
M. Douša, J. Srbek, S. Rádl, J. Cerný, O. Klecán, J. Havlíček, M. Tkadlecová, T. Pekárek, P. Gibala, L. Nováková,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- fenylendiaminy chemie MeSH
- karbamáty chemie MeSH
- kontaminace léku MeSH
- limita detekce MeSH
- referenční standardy MeSH
- stabilita léku MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- Publikační typ
- časopisecké články MeSH
Two new impurities were described and determined using gradient HPLC method with UV detection in retigabine (RET). Using LC-HRMS, NMR and IR analysis the impurities were identified as RET-dimer I: diethyl {4,4'-diamino-6,6'-bis[(4-fluorobenzyl)amino]biphenyl-3,3'-diyl}biscarbamate and RET-dimer II: ethyl {2-amino-5-[{2-amino-4-[(4-fluorobenzyl) amino] phenyl} (ethoxycarbonyl) amino]-4-[(4-fluorobenzyl)amino] phenyl}carbamate. Reference standards of these impurities were synthesized followed by semipreparative HPLC purification. The mechanism of the formation of these impurities is also discussed. An HPLC method was optimized in order to separate, selectively detect and quantify all process-related impurities and degradation products of RET. The presented method, which was validated in terms of linearity, limit of detection (LOD), limit of quantification (LOQ) and selectivity is very quick (less than 11min including re-equilibration time) and therefore highly suitable for routine analysis of RET related substances as well as stability studies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008292
- 003
- CZ-PrNML
- 005
- 20150327120014.0
- 007
- ta
- 008
- 150306s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2014.01.042 $2 doi
- 035 __
- $a (PubMed)24552644
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Douša, Michal $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
- 245 10
- $a Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine / $c M. Douša, J. Srbek, S. Rádl, J. Cerný, O. Klecán, J. Havlíček, M. Tkadlecová, T. Pekárek, P. Gibala, L. Nováková,
- 520 9_
- $a Two new impurities were described and determined using gradient HPLC method with UV detection in retigabine (RET). Using LC-HRMS, NMR and IR analysis the impurities were identified as RET-dimer I: diethyl {4,4'-diamino-6,6'-bis[(4-fluorobenzyl)amino]biphenyl-3,3'-diyl}biscarbamate and RET-dimer II: ethyl {2-amino-5-[{2-amino-4-[(4-fluorobenzyl) amino] phenyl} (ethoxycarbonyl) amino]-4-[(4-fluorobenzyl)amino] phenyl}carbamate. Reference standards of these impurities were synthesized followed by semipreparative HPLC purification. The mechanism of the formation of these impurities is also discussed. An HPLC method was optimized in order to separate, selectively detect and quantify all process-related impurities and degradation products of RET. The presented method, which was validated in terms of linearity, limit of detection (LOD), limit of quantification (LOQ) and selectivity is very quick (less than 11min including re-equilibration time) and therefore highly suitable for routine analysis of RET related substances as well as stability studies.
- 650 _2
- $a karbamáty $x chemie $7 D002219
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a kontaminace léku $7 D004340
- 650 _2
- $a stabilita léku $7 D004355
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a fenylendiaminy $x chemie $7 D010655
- 650 _2
- $a referenční standardy $7 D012015
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Srbek, Jan $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Rádl, Stanislav $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Cerný, Josef $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Klecán, Ondřej $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Havlíček, Jaroslav $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Tkadlecová, Marcela $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Pekárek, Tomáš $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Gibala, Petr $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Nováková, Lucie $u Department of Analytical Chemistry, Charles University, Faculty of Pharmacy, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 94, č. - (2014), s. 71-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24552644 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150327120336 $b ABA008
- 999 __
- $a ok $b bmc $g 1065565 $s 891092
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 94 $c - $d 71-6 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20150306